Home | Virology | Coronavirus (COVID-19) | Congress activities | Italian Congress on AIDS and Antiretroviral Research (ICAR)

Italian Congress on AIDS and Antiretroviral Research (ICAR)

View all WMF ICAR

The Italian Congress on AIDS and Antiretroviral Research (ICAR) meets annually to discuss the crucial issues in the battle against HIV infection and other viral infections. It combines a mix of basic, translational, and clinical research with the opportunity for interactions between the scientific community, patients and the wider public.

Please select the resource of interest below:

Italian Congress on AIDS and Antiretroviral Research (ICAR)
ICAR 2021 Poster: The dihydroorotate dehydrogenase (DHODH) inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines implicated in COVID-19 disease and is currently being evaluated in the FITE19 clinical trial in hospitalized patients
This poster, presented at the 2021 ICAR virtual meeting, shows results from experiments to investigate a novel DHODH inhibitor as a potential treatment for COVID-19 
Italian Congress on AIDS and Antiretroviral Research (ICAR)
ICAR 2021 abstract: The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines implicated in severe COVID-19 disease and is currently being evaluated in the FITE19 clinical trial in hospitalized patients 
This abstract, presented at the 2021 ICAR virtual conference, reports on a novel dihydroorotate dehydrogenase (DHODH) inhibitor as a possible treatment for COVID-19  
Year
Topic
Therapy area
Congress
Type
MED-ALL-COVID-2100040 | October 2021
Sign in or register to access exclusive content on this site 
  REGISTER

Welcome to MEDhub

A website for healthcare professionals, provided by PTC Therapeutics

This educational website provides you with the latest scientific data and expert
insights on the diagnosis and management of a range of rare diseases across the neuromuscular system, central nervous system, and other areas

This content is protected. To view it please enter your email address below:

Register here to access the content on the site
MED-ALL-CORP-2200029 | December 2022

COMING SOON

The content you are trying to access is not currently available.

We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.